Actavis Said To Be in Talks With Allergan on $60B Deal

The transcript discusses a potential acquisition involving a drug company known for Botox and implants, with rival drugmaker Activist in talks to buy it for $60 billion. Bill Ackman, a major shareholder, plays a significant role in the proceedings. The discussion includes stock performance of Activist and Allergan, and the involvement of hedge funds like Third Point and Blue Ridge. Key players and their strategies are highlighted, providing insights into the financial maneuvers surrounding the acquisition.

What is the minimum amount Activist is considering to offer for Allergan?

• $70 billion

• $50 billion

• $60 billion

• $80 billion

Who is Allergan's largest shareholder involved in the acquisition talks?

• Dan Loeb

• Larry Robbins

• John Griffin

• Bill Ackman

Which hedge fund is not mentioned as having a large position in Activist?

• Glenview Capital

• Lone Pine Capital

• Third Point

• Geo Capitals

Which hedge fund is run by John Griffin?

• Lone Pine Capital

• Third Point

• Geo Capitals

• Blue Ridge

What is the approximate size of the Blue Ridge fund?

• $6 billion

• $7 billion

• $5 billion

• $8 billion